TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998